Quality of life after liver transplantation in patients with familial amyloidotic polyneuropathy

Amyloid

Volumn 3, Issue 2, 1996, Pages 124-129

  Jonsén, Elisabeth ^a   Suhr, Ole ^a   Athlin, Elsy ^b   Wikström, Lars ^c  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b ÖSTERSUND HOSPITAL   (Sweden)

^c Skelleftea Hospital   (Sweden)

Author keywords

FAP; Liver transplantation; Quality of life

Indexed keywords

EID: 0000410360     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129609014364     Document Type: Article

References (30)

1. Andrade C (1952). A peculiar form of peripheral neuropathy. Familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75, 408-427
2. Andersson R (1976). Familial amyloidosis with polyneuropathy: A clinical study based on patients living in Northem Sweden. Acta Med Scand 198 (Suppl 590), 1-64
3. Saraiva M, Costa P, Burken S and Goodman D (1983). Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with amyloidatic polyneuropathy. Trans Assoc Am Phys 96, 261-270
4. Coutinho P, Martins da Silva A, Kopes Lima J and Resende Barbosa A (1980). Forty years of experience with type I amyloid neuropathy. Review of 483 cases. In Coutinho P, Martins da Silva A, Kopes Lima J and Resende Barbosa A, (eds.) Amyloid and Amyloidosis, pp. 88-98 (Amsterdam: Excerpta Medica)
5. 30 carriers in Northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 31, 351-354
6. Tawara S, Nakazato M, Kangawa K, Matsuo H and Araki S (1983). Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Comm 116, 880-888
7. Dwulet F and Benson M (1983). Polymorphism of human plasma thyroxine binding prealbumin. Biochem Biophys Res Comm 114, 657-662
8. Sandgren O, Drugge U, Holmgren G and Sousa A (1991). Vitreous involvement in familial amyloidotic neuropathy: a genealogical and genetic study. Clin Genet 40, 452-460
9. Andersson R and Kassman T (1968). Vitreous opacities in primary familial amyloidosis. Acta Ophthalmol (Copenh) 46, 441-447
10. Olofsson BO, Grankvist K, Boman K, Forsberg K, Lafvas I and Lithner F (1989). Assessment of thyroid and adrenal function in patients with familial amyloidotic polyneuropathy. J Intern Med 225, 337-341
11. Bjerle P, Ek B, Linderholm H and Steen L (1993). Oesophageal dysfunction in familial amyloidosis with polyneuropathy. Clin Physiol 13, 57-69
12. Bergfeldt BL, Olofsson BO and Edhag KO (1985). Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy. Am J Cardiol 56, 647-652
13. de Freitas A (1986). The heart in Portuguese amyloidosis. Postgrad Med J 62, 601-605
14. Eriksson P, Boman K, Jacobsson B and Olofsson BO (1986). Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia. Acta Anaesthesiol Scand 30, 317-320
15. Olofsson B-O, Suhr O, Niklasson U, Wiklund U, Bjerle P and Beckman A (1994). Assessment of autonomic nerve function in familial amyloidotic polyneuropathy: a clinical study based on spectral analysis of heart rate variability. Amyloid Int J Exp Clin Invest 1, 240-246
16. Steen L and Ek B (1984). Familial amyloidosis with polyneuropathy. A long term follow up of 21 patients with special reference to gastrointestinal symptoms. Acta Med Scand 214, 387-397
17. Suhr O, Danielsson Å and Steen L (1992). Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of patients with familial amyloidosis with polyneuropathy. Scand J Gastroentrol 27, 201-207
18. Suhr O, Danielsson Å, Holmgren G and Steen L (1994). Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Int Med 235, 479-485
19. 30). Clin Genet 40, 242-246
20. Steen L, Holmgren G, Suhr O, Wikström L, Groth C-G and Ericzon BG (1994). World-wide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid Int J Exp Clin Invest 1, 138-142
21. Lewis W, Skinner M, Simms R, Jones L, Cohen A and Jenkins R (1994). Orthotopic liver transplantation for familial amyloidotic polyneuropathy. Clin Transpl 8, 107-110
22. Holmgren G, Ericzon B-G, Groth C-G, Steen L, Suhr O, Andersson O, Wallin B, Seymor A, Richardson S, Hawkins P and Pepys M (1993). Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341, 1113-1116
23. Suhr O, Holmgren G, Steen L, Wikström L, Nordén G, Friman S, Duraj F, Groth C-G and Ericzon B-G (1995). Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 60, 933-938
24. Gunnars B (1991). Quality of life during chemotherapy treatment. Thesis pp. 271-284 (Lund: Lund's University)
25. Kamofsky DA and Burchenal JH (1949). The clinical evaluation of chemotherapeutic agents in cancer. In Kamofsky DA and Burchenal JH, (eds.) Evaluation of Chemotherapeutic Agents in cancer, pp. 191-205 (New York: Colombia University Press)
26. Stensman R (1985). Severley mobility-disabled people assess the quality of their lives. Scand J Rehab Med 17, 87-99
27. Trzepacz PT, Maue FR and Coffman G (1986). Neuropsychiatric assessment of liver transplantation candidates: delirium and other psychiatric disorders. Int J Psychiatry Med 16, 101-111
28. Trzepacz PT, Brenner R and Van Thiel DH (1989). A psychiatric study of 247 liver transplantation candidates. J Psychosomatic Res 30, 147-153
29. Heyink JW and Tymstra T (1990). Liver transplantation: the shadow side. Family Practice 7, 233-237
30. Commander M, Neuberger J and Dean C (1992). Psychiatric and social consequences of liver transplantation. Transplantation 53, 1038-1040